Literature DB >> 15530658

Stress induced changes in cortical and hypothalamic c-fos expression are altered in fragile X mutant mice.

Julie C Lauterborn1.   

Abstract

Fragile X (FraX) syndrome is characterized by mental retardation and a behavioral phenotype that includes stress-related behaviors. Recently, FraX children were shown to have elevated glucocorticoid hormones under basal conditions and an exaggerated hormonal response to stress. In the present study, fragile X mental retardation 1-knockout (Fmr1-KO) and wild-type (WT) mice were subjected to immobilization stress for 30 min or 2 h, killed with paired controls, and the hippocampus, neocortex, and hypothalamic paraventricular nucleus (PVN) assessed by in situ hybridization for effects on c-fos mRNA. The main effect of stress in hippocampus was a reduction in mRNA levels within CA3-CA1 pyramidal cells in both genotypes. Stress significantly reduced CA1 c-fos mRNA in Fmr1-KOs at 30 min (-41%) and 2 h (-57%), whereas in WTs levels were significantly reduced only at 2 h (-57%). In neocortex, 30 min stress significantly increased c-fos mRNA in Fmr1-KOs only (+53%); however, by 2 h levels were reduced in both genotypes versus respective controls. In the paraventricular nucleus, c-fos mRNA levels were significantly, and equally, increased in both genotypes at 30 min. However, at 2 h, mRNA levels were still elevated in the Fmr1-KOs, whereas they had returned to control values in the WTs. Finally, immobilization stress significantly increased serum corticosterone levels in both genotypes at 30 min and 2 h, with Fmr1-KOs exhibiting greater levels than WTs; levels were statistically different at 2 h. These data indicate a greater response to stress in FraX mutants than in WTs, and further support the hypothesis of a dysregulated hypothalamic-pituitary-adrenal (HPA) axis in FraX syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530658     DOI: 10.1016/j.molbrainres.2004.08.014

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  8 in total

1.  Effects of chronic immobilization stress on anxiety-like behavior and basolateral amygdala morphology in Fmr1 knockout mice.

Authors:  M Qin; Z Xia; T Huang; C B Smith
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

2.  The Fragile X proteins Fmrp and Fxr2p cooperate to regulate glucose metabolism in mice.

Authors:  Jeannette G Lumaban; David L Nelson
Journal:  Hum Mol Genet       Date:  2014-12-30       Impact factor: 6.150

3.  Environmental enrichment reveals effects of genotype on hippocampal spine morphologies in the mouse model of Fragile X Syndrome.

Authors:  Julie C Lauterborn; Matiar Jafari; Alex H Babayan; Christine M Gall
Journal:  Cereb Cortex       Date:  2013-09-17       Impact factor: 5.357

4.  Morphometric spatial patterns differentiating boys with fragile X syndrome, typically developing boys, and developmentally delayed boys aged 1 to 3 years.

Authors:  Fumiko Hoeft; Amy A Lightbody; Heather Cody Hazlett; Swetapadma Patnaik; Joseph Piven; Allan L Reiss
Journal:  Arch Gen Psychiatry       Date:  2008-09

5.  Unaltered hormonal response to stress in a mouse model of fragile X syndrome.

Authors:  Mei Qin; Carolyn Beebe Smith
Journal:  Psychoneuroendocrinology       Date:  2008-05-13       Impact factor: 4.905

Review 6.  Fragile X syndrome: an update on developing treatment modalities.

Authors:  Aileen Healy; Roger Rush; Timothy Ocain
Journal:  ACS Chem Neurosci       Date:  2011-03-22       Impact factor: 4.418

7.  Resilience to audiogenic seizures is associated with p-ERK1/2 dephosphorylation in the subiculum of Fmr1 knockout mice.

Authors:  Giulia Curia; Fabio Gualtieri; Regina Bartolomeo; Riccardo Vezzali; Giuseppe Biagini
Journal:  Front Cell Neurosci       Date:  2013-04-25       Impact factor: 5.505

8.  Functional magnetic resonance imaging in awake transgenic fragile X rats: evidence of dysregulation in reward processing in the mesolimbic/habenular neural circuit.

Authors:  W M Kenkel; J R Yee; K Moore; D Madularu; P Kulkarni; K Gamber; M Nedelman; C F Ferris
Journal:  Transl Psychiatry       Date:  2016-03-22       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.